Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Carving Out Strategic Strengths In Emerging Markets: Euro-Biotech Partnering Summit

This article was originally published in PharmAsia News

Executive Summary

GSK VP Paul Bolno on market-specific opportunities in Asia.

You may also be interested in...



Is China A Black Swan For Big Pharma? (Part 2 of 2)

[Editor's note: This is part two of a two part story; part one appeared in PharmAsia News, April 25, 2010.]

Beijing Firm Launches Clinical Trial On Stem Cell Treatment For Diabetes

BEIJING - The chief executive officer of the Beijing-headquartered firm Cellonis says that preliminary results from an ongoing clinical trial in the Chinese capital are a promising sign of the potential for widening use of a stem cell-based treatment for diabetes in the future

Southeast Asian Regulators Ramp Up Anti-Corruption, Bribery Enforcement Ahead of ASEAN Pact

Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.

Topics

Related Companies

UsernamePublicRestriction

Register

SC081831

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel